Illumina Inc

Article Abstract:

The article provides the price appreciation potential of the shares of Illumina Inc. for the years 2010-2012. The company offers next-generation tools for large-scale analysis of genetic variation and function, curing disease, improving drugs and therapies, and customizing diagnoses and treatment.

Author: Rho, George

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Illumina, Inc

Article Abstract:

The significant progress in the market penetration of BeadArray Technology of Illumina, Inc. is discussed. A comparative analysis of the sales earnings and the financial details from the year 1998-2003 are detailed. Different financial ratios according to the Value Line Publication are given.

Author: Kuboyama, C.F.
United States, Sales, profits & dividends, Comparative analysis, Company sales and earnings, Company earnings/profit

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Illumina, Inc

Article Abstract:

The price appreciation potential of the shares of Illumina Inc. for the years 2010-2012 is discussed. The San Diego, California-based company develops tools for large-scale analysis of genetic variation and function.

Author: Rho, George
Commercial physical research, Biological products exc. diagnostic, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Securities, Stock prices, Company securities, Illumina Inc.
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.